Invesco Ltd. Merck & Co., Inc. Transaction History
Invesco Ltd.
- $516 Billion
- Q4 2024
A detailed history of Invesco Ltd. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Invesco Ltd. holds 15,452,240 shares of MRK stock, worth $1.46 Billion. This represents 0.3% of its overall portfolio holdings.
Number of Shares
15,452,240
Previous 12,604,306
22.59%
Holding current value
$1.46 Billion
Previous $1.43 Billion
7.39%
% of portfolio
0.3%
Previous 0.29%
Shares
25 transactions
Others Institutions Holding MRK
# of Institutions
3,966Shares Held
1.94BCall Options Held
16MPut Options Held
15M-
Vanguard Group Inc Valley Forge, PA251MShares$23.8 Billion0.45% of portfolio
-
Black Rock Inc. New York, NY207MShares$19.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA121MShares$11.5 Billion0.49% of portfolio
-
Wellington Management Group LLP Boston, MA80.7MShares$7.65 Billion1.51% of portfolio
-
Geode Capital Management, LLC Boston, MA61.2MShares$5.8 Billion0.48% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $240B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...